etherna, a biotech company specialising in mRNA and lipid nanoparticle [...]
MaxCyte, Inc. has launched ExPERT DTx, a 96-well electroporation platform [...]
Almirall delivered net sales growth of 12.4% in 2025, surpassing [...]
Abivax has presented new preclinical and clinical data for obefazimod [...]
Hansa Biopharma’s Biologics License Application (BLA) for imlifidase has been [...]
Lonza expands its Advanced Synthesis capabilities at Oss, integrating ADC [...]
Oncoinvent will present final 24-month follow-up data from its Phase [...]
Scribe Therapeutics secures milestone $1.5BN collaboration with Eli Lilly for in vivo CRISPR program
Scribe Therapeutics has achieved a second success milestone in its [...]
Kidswell Bio and Treehill Partners have launched a US-based regenerative [...]
CellProthera has acquired full rights to the transendocardial catheter originally [...]